Patents by Inventor Cynthia Ann CECH

Cynthia Ann CECH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-hemolysin variants
    Patent number: 11261488
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: March 1, 2022
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Timothy Kellogg Craig, Cynthia Ann Cech, Michael Dorwart, Liv Elisabeth Jensen, Marshall Winston Porter, Christos Tzitzilonis, Alexander Hyun-min Yang
  • ALPHA-HEMOLYSIN VARIANTS
    Publication number: 20200325534
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: June 30, 2020
    Publication date: October 15, 2020
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG
  • Alpha-hemolysin variants
    Patent number: 10752948
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Grant
    Filed: January 3, 2019
    Date of Patent: August 25, 2020
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Timothy Kellogg Craig, Cynthia Ann Cech, Michael Dorwart, Liv Elisabeth Jensen, Marshall Winston Porter, Christos Tzitzilonis, Alexander Hyun-min Yang
  • Alpha-Hemolysin Variants
    Publication number: 20190119745
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: January 3, 2019
    Publication date: April 25, 2019
    Applicant: GENIA TECHNOLOGIES, INC.
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG
  • Alpha-hemolysin variants
    Patent number: 10227645
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: March 12, 2019
    Assignee: GENIA TECHNOLOGIES, INC.
    Inventors: Timothy Kellogg Craig, Cynthia Ann Cech, Michael Dorwart, Liv Elisabeth Jensen, Marshall Winston Porter, Christos Tzitzilonis, Alexander Hyun-min Yang
  • Alpha-Hemolysin Variants
    Publication number: 20170088890
    Abstract: Described herein are engineered alpha-hemolysin subunits having mutated oligomerization domains for assembling into heptameric nanopores in lipid bilayers.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 30, 2017
    Inventors: Timothy Kellogg CRAIG, Cynthia Ann CECH, Michael DORWART, Liv Elisabeth JENSEN, Marshall Winston PORTER, Christos TZITZILONIS, Alexander Hyun-min YANG